Michael D. Amylon
Stanford University
82 Papers
1.8K Citations
Michael D. Amylon is an academic researcher from Stanford University. The author has contributed to research in topics: Acute lymphocytic leukemia & Leukemia. The author has an hindex of 39, co-authored 82 publications. Previous affiliations of Michael D. Amylon include St. Jude Children's Research Hospital & San Jose State University.
Chat about Author
Papers
Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.
Michael D. Amylon,J J Shuster,Jeanette Pullen,Costan W. Berard,Michael P. Link,Moody D. Wharam,J A Katz,Alice L. Yu,Joseph Laver,Yaddanapudi Ravindranath,Joanne Kurtzberg,S Desai,Bruce M. Camitta,Sharon B. Murphy +13 more
TL;DR: It is concluded that when added to a backbone of effective rotating agents, repeated doses of asparaginase during early treatment improve the outcome for patients with T cell leukemia and advanced stage lymphoblastic lymphoma.
346
Pleuropulmonary blastoma: A marker for familial disease
John R. Priest,Jan Watterson,Louise Strong,Vicki Huff,William G. Woods,Rebecca L. Byrd,Stephen H. Friend,Irene Newsham,Michael D. Amylon,Alberto Pappo,Donald H. Mahoney,Claire Langston,Ruth Heyn,Gloria Kohut,David R. Freyer,Bruce Bostrom,Mary S. Richardson,Julio C. Barredo,Louis P. Dehner +18 more
TL;DR: The occurrence of PPB appears to herald a constitutional and heritable predisposition to dysplastic or neoplastic disease in approximately 25% of cases and patients with PPB and their families should be investigated carefully.
228
A Single Monoclonal Antibody Identifies T-Cell Lineage of Childhood Lymphoid Malignancies
Michael P. Link,Michael P. Link,Roger A. Warnke,Roger A. Warnke,Jonathan L. Finlay,Jonathan L. Finlay,Michael D. Amylon,Michael D. Amylon,Richard A. Miller,Richard A. Miller,Jeanette Dilley,Jeanette Dilley,Ronald Levy,Ronald Levy +13 more
TL;DR: Monoclonal antibody 4H9 is a sensitive and specific reagent for the identification of childhood T- cell ALL and NHL and should be extremely useful in immunophenotyping studies of lymphoid malignancies.
150
Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study.
Gaston K. Rivera,George R. Buchanan,James M. Boyett,Bruce M. Camitta,Judith Ochs,David K. Kalwinsky,Michael D. Amylon,Teresa J. Vietti,William M. Crist +8 more
TL;DR: Intensive chemotherapy, as described here, may save half of the children with acute lymphoblastic leukemia in whom bone marrow relapse occurs after a relatively long initial remission.
146
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases.
Nancy R. Schneider,Andrew J. Carroll,Jonathan J. Shuster,D. Jeanette Pullen,Michael P. Link,Michael J. Borowitz,Bruce M. Camitta,Julie A. Katz,Michael D. Amylon +8 more
TL;DR: This study suggests that there may be survival differences associated with some T-ALL blast cell karyotypes, and 12 aberrations found in this series are targets for discovery and characterization of new genes that are important in T-cell development and leukemogenesis.
127